DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization
Status:
Withdrawn
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, double-blind, double-dummy, and controlled study of
DLBS1033 in the management of acute non-ST elevation myocardial infarction (NSTEMI) without
early coronary revascularization. It is hypothesized that the combination of DLBS1033 with
aspirin and clopidogrel will result in greater reduction of infarct size in comparison with
that of aspirin and clopidogrel alone.